FierceBiotech 10 feb 2026 Kailera, Hengrui tout up to 12% weight loss in midstage study for obesity pill
FierceBiotech 10 feb 2026 Merck teams up with British medtech to boost vaginal therapeutics delivery system
FierceBiotech 10 feb 2026 AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data
FierceBiotech 10 feb 2026 Nektar eczema candidate 'checked all of the boxes' in long-term phase 2 data
FierceBiotech 10 feb 2026 FDA rejects Regenxbio's gene therapy in Hunter syndrome, leaving CEO 'concerned'
FierceBiotech 9 feb 2026 FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils
FierceBiotech 9 feb 2026 Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
FierceBiotech 9 feb 2026 CSL signs on to $328M research collab with option for Memo’s immunoglobulin antibody tech
FierceBiotech 9 feb 2026 The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align
FierceBiotech 6 feb 2026 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
FierceBiotech 6 feb 2026 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study